Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect on bone mineralization of continued growth hormone therapy at the transition between childhood and adulthood.

Endocrine connections·2026
Same author

[Guidelines from the SP2A (Pediatric Society of Pulmonology and Allergology) for the management of asthma in children aged 6 to 12years (without management of asthma exacerbation) - Short version].

Revue des maladies respiratoires·2025
Same author

[Palpebral ophthalmomyiasis: Case report].

Journal francais d'ophtalmologie·2024
Same author

Risk factors for lower border notching after bilateral mandibular sagittal ramus advancement: three-dimensional evaluation.

International journal of oral and maxillofacial surgery·2022
Same author

High performance recycled CFRP composites based on reused carbon fabrics through sustainable mild solvolysis route.

Scientific reports·2022
Same author

Uranium retention in a Callovo-Oxfordian clay rock formation: From laboratory-based models to in natura conditions.

Chemosphere·2022

Related Experiment Video

Updated: Apr 12, 2026

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

11.4K

Vaccine coverage in CF children: A French multicenter study.

A Masson1, O Launay2, B Delaisi3

  • 1Assistance-Publique Hôpitaux de Paris, Hôpital Necker, Service de Pneumologie-Allergologie Pédiatrique et Centre de Ressources et de Compétences en Mucoviscidose, Paris, France.

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|May 20, 2015
PubMed
Summary

Vaccine coverage for mandatory and recommended vaccines is low in children with cystic fibrosis (CF), indicating a need for improved immunization strategies in this vulnerable population.

Keywords:
Cystic fibrosisHepatitis BImmunizationInfluenzaVaccine coverage

More Related Videos

Three-Dimensional Ultrasonic Needle Tip Tracking with a Fiber-Optic Ultrasound Receiver
04:33

Three-Dimensional Ultrasonic Needle Tip Tracking with a Fiber-Optic Ultrasound Receiver

Published on: August 21, 2018

11.0K
Nanothermite with Meringue-like Morphology: From Loose Powder to Ultra-porous Objects
07:46

Nanothermite with Meringue-like Morphology: From Loose Powder to Ultra-porous Objects

Published on: December 24, 2017

8.2K

Related Experiment Videos

Last Updated: Apr 12, 2026

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

11.4K
Three-Dimensional Ultrasonic Needle Tip Tracking with a Fiber-Optic Ultrasound Receiver
04:33

Three-Dimensional Ultrasonic Needle Tip Tracking with a Fiber-Optic Ultrasound Receiver

Published on: August 21, 2018

11.0K
Nanothermite with Meringue-like Morphology: From Loose Powder to Ultra-porous Objects
07:46

Nanothermite with Meringue-like Morphology: From Loose Powder to Ultra-porous Objects

Published on: December 24, 2017

8.2K

Area of Science:

  • Pediatric Infectious Diseases
  • Pulmonology
  • Immunology

Background:

  • Low vaccine coverage is a concern in chronic disease patients.
  • Data on vaccination status in cystic fibrosis (CF) patients are limited.
  • Optimizing care for CF patients requires understanding their immunization levels.

Purpose of the Study:

  • To assess vaccination coverage for mandatory and recommended vaccines in cystic fibrosis patients.
  • To compare vaccine coverage in CF patients to the general population.
  • To identify gaps in immunization for CF care optimization.

Main Methods:

  • Prospective study utilizing data from the "MucoFlu" study (2009).
  • Data collected from 5 cystic fibrosis centers in the Paris metropolitan area.
  • Vaccination status from health booklets compared to general population data.

Main Results:

  • 134 CF children were included in the analysis.
  • Insufficient coverage for mandatory vaccines (DTPCaHi, pneumococcal, BCG, MMR, hepatitis B) at 1 year, with no catch-up.
  • Low coverage for recommended CF vaccines: hepatitis A, non-conjugate pneumococcal, and varicella.
  • High coverage for seasonal influenza (66%) and pandemic flu (91%) in 2009.

Conclusions:

  • Significant deficits in vaccine coverage exist for both routine and CF-specific immunizations in this patient group.
  • The findings highlight a critical need for enhanced vaccination strategies in cystic fibrosis care.
  • Addressing these coverage gaps is essential for improving health outcomes in children with CF.